Teleflex Announces Extension of Arrow™ ErgoPack™ Complete System to Hemodialysis and Large Bore Central Venous Catheters
August 21 2023 - 6:30AM
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies, today announced the release of the Arrow™
ErgoPack™ Complete Kits with Hemodialysis and Large Bore catheters
in the United States. This update is intended to streamline
insertion workflow for clinicians and provide more options to suit
their needs. Clinicians can choose between Arrowg+ard Blue™
Hemodialysis or Large Bore lines in this expanded kit
configuration, with a variety of French sizes, lumens, and lengths.
Learn more about the Arrow™ ErgoPack™ Complete System.
The Arrow™ ErgoPack™ Complete System expansion includes a
variety of clinician-inspired updates:
- The Arrow™ GlideWheel™ Advancer, which provides tactile
feedback and finer control
- Nitinol Guidewire, which is kink-resistant compared to
stainless steel
- Transducer Cover to support guidelines for ultrasound use
- Pre-filled sterile saline syringes, one per catheter lumen
- Extra ChloraPrep® Skin Prep in each kit
- Option of 3M™ Tegaderm™ CHG I.V. Securement Dressing or 3M™
Tegaderm™ I.V. Advanced Securement Dressing with BioPatch®
Protective Disk
“Max barrier kits like the Arrow™ ErgoPack™ Complete System
provide clinicians with the necessary components they need for
their Acute Hemodialysis and Large Bore insertions. The intuitive
configuration is designed to optimize their workflow, while also
meeting the recommendations of CDC, SHEA, INS, and OSHA
guidelines.1-4 Coupling these benefits along with the protection
from Arrowg+ard Blue™ Catheters helps clinicians fight against
central line-associated bloodstream infections, protecting their
patients and improving their procedures.” – said Lisa Kudlacz,
President and General Manager, Vascular Access at Teleflex.
The Arrow™ ErgoPack™ Complete System’s unique combination of CVC
insertion components is packaged in an ergonomic and efficient top
down, left to right configuration, and helps central line inserters
meet the recommendations of critical third-party independent
guidelines for reducing CLABSI, including:
- Centers for Disease Control and Prevention (CDC) Category 1A
& 1B recommendations1
- Society for Hospital Epidemiology of America (SHEA)
Guidelines2
- Infusion Nursing Society (INS) Standards of Practice3
- Occupational Health and Safety Administration (OSHA) Bloodborne
Pathogens Standard4
About Teleflex IncorporatedTeleflex is a global
provider of medical technologies designed to improve the health and
quality of people’s lives. We apply purpose driven innovation – a
relentless pursuit of identifying unmet clinical needs – to benefit
patients and healthcare providers. Our portfolio is diverse, with
solutions in the fields of vascular access, interventional
cardiology and radiology, anesthesia, emergency medicine, surgical,
urology and respiratory care. Teleflex employees worldwide are
united in the understanding that what we do every day makes a
difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow™, Deknatel™, LMA™, Pilling™,
QuikClot™, Rusch™, UroLift™ and Weck™ – trusted brands united by a
common sense of purpose.
Forward-Looking StatementsAny statements
contained in this press release that do not describe historical
facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which
may cause actual results or company actions to differ materially
from what is expressed or implied by these statements. These risks
and uncertainties are identified and described in more detail in
our filings with the Securities and Exchange Commission, including
our Annual Report on Form 10-K.
References:
- O’Grady NP, Alexander M, Burns LA,
et al. Guidelines for the Prevention of Intravascular
Catheter-Related Infections, 2011 (Revised 2017). 2. Atlanta, GA:
Centers for Disease Control and Prevention; 2017.
- Buetti, N., Marschall, J., Drees,
M., Fakih, M., Hadaway, L., Maragakis, L., Mermel, L. (2022).
Strategies to prevent central line-associated bloodstream
infections in acute-care hospitals: 2022 Update. Infection Control
& Hospital Epidemiology, 1-17. doi:10.1017/ice.2022.87.
- Gorski, Lisa A., et al. "Infusion
therapy standards of practice." Journal of Infusion Nursing, 44.1S
(2021): S1-S224.
- Occupational Safety & Health Administration Regulations
(Standards – 29 CFR). Part 1910.1030: Bloodborne pathogens.
Occupational Safety & Health Administration Web site.
https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030.
Accessed on February 12, 2020.
Rx Only
Contraindication:Arrowg+ard Blue™ Acute Hemodialysis and Large
Bore Catheters are contraindicated for patients with known
hypersensitivity to chlorhexidine and silver sulfadiazine and/or
sulfa drugs.
3M and Tegaderm are registered trademarks of 3M or its
affiliates. BioPatch is a registered trademark of Johnson &
Johnson or its affiliates. ChloraPrep is a registered trademark of
Becton, Dickinson and Company or its affiliates.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue, Deknatel,
ErgoPack, GlideWheel, LMA, Pilling, QuikClot, Rusch, UroLift, and
Weck are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries.
All other marks are the property of their respective owners.© 2023
Teleflex Incorporated. All rights reserved. MC-008913
Contact:Teleflex Incorporated:Lawrence
KeuschVice President, Investor Relations and Strategy
Development
investors.teleflex.com
610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2024 to May 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From May 2023 to May 2024